We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sigma Labs Inc | NASDAQ:SGLB | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.05 | 1.03 | 1.07 | 0 | 01:00:00 |
As filed with the Securities and Exchange Commission on November 30, 2018 | Registration No. 333-______ |
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION
STATEMENT UNDER
THE SECURITIES ACT OF 1933
SIGMA LABS, INC.
(Exact name of registrant as specified in its charter)
Nevada | 27-1865814 | |
(State
or other jurisdiction of
incorporation or organization) |
(I.R.S.
Employer
Identification No.) |
3900 Paseo del Sol
Santa Fe, NM 87507
(505) 438-2576
(Address of principal executive offices)
2013 EQUITY INCENTIVE PLAN, AS AMENDED, OF SIGMA LABS, INC.
(Full title of the plan)
John Rice, President and Chief Executive Officer
Sigma Labs, Inc.
3900 Paseo del Sol
Santa Fe, NM 87507
(Name and address of agent for service)
(505)
438-2576
(Telephone number, including area
code, of agent for service)
Copy
to:
Darren Freedman
TroyGould PC
1801 Century Park East, Suite 1600
Los Angeles, California 90067
(310) 553-4441
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
[ ] Large accelerated filer | [ ] Accelerated filer | [X] Non-accelerated filer | [X] Smaller reporting company |
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [ ]
CALCULATION OF REGISTRATION FEE
Title of securities to be registered |
Amount
to be
registered (1) |
Proposed
per share |
Proposed
maximum aggregate offering price |
Amount of registration fee | |||||||||||
Common Stock, $0.001 par value per share | 851,149 shares (2) | $ | 1.49 | (2) | $ | 1,268,212.01 | (2) | $ | 153.71 | ||||||
Common Stock, $0.001 par value per share | 48,851 shares (3) | $ | 1.79 | (3) | $ | 87,443.29 | (3) | $ | 10.60 | ||||||
Total | 900,000 shares | — | $ | 1,355,655.30 | $ | 164.31 |
(1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement covers, in addition to the shares of common stock specified above, an indeterminate number of additional shares of common stock that may become issuable under the 2013 Equity Incentive Plan, as amended (the “Plan”), as a result of the anti-dilution adjustment provisions contained therein regarding stock splits, stock dividends and similar transactions. | |
(2) | Represents shares reserved for issuance pursuant to future awards under the Plan. The proposed maximum offering price per share and maximum aggregate offering price for these shares were estimated pursuant to Rules 457(c) and 457(h) of the Securities Act on the basis of the $1.49 average of the high and low trading prices of the registrant’s common stock, as reported on The NASDAQ Capital Market on November 23, 2018. | |
(3) | Represents shares issuable upon the exercise of outstanding options under the Plan. The proposed maximum offering price per share and maximum aggregate offering price for these shares were estimated pursuant to Rule 457(h) of the Securities Act on the basis of the exercise price of such options of $1.79 per share. |
EXPLANATORY NOTE
This Registration Statement is filed pursuant to General Instruction E to Form S-8 by Sigma Labs, Inc., a Nevada corporation (the “Company”), to register 900,000 shares of common stock of the Company in addition to those previously registered on the Company’s Registration Statements on Form S-8 (File Nos. 333-197616, 333-212612 and 333-222369) filed with the Securities and Exchange Commission on July 24, 2014, July 21, 2016 and December 29, 2017, respectively, for issuance pursuant to the Company’s 2013 Equity Incentive Plan. Pursuant to General Instruction E to Form S-8, this Registration Statement incorporates by reference the contents of such previously filed Registration Statements, except that the provisions contained in Part II of such earlier Registration Statements are modified as set forth in this Registration Statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. | Incorporation of Documents by Reference |
We hereby incorporate by reference the following documents previously filed with the SEC:
● | Our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 filed on April 17, 2018; | |
● | Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2018 filed on May 15, 2018, Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 filed on August 14, 2018, and Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed on November 14, 2018; | |
● | Our Current Reports on Form 8-K filed on January 17, 2018, January 24, 2018, February 27, 2018, March 6, 2018, April 6, 2018, April 25, 2018, May 24, 2018, June 26, 2018, August 7, 2018, September 14, 2018 and October 23, 2018, respectively; and | |
● | The description of our stock contained in our registration statement on Form 8-A filed on February 14, 2017 pursuant to Section 12 of the Exchange Act, and any amendment or report filed for the purpose of updating such description. |
All documents filed by Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents. Any statement contained in this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed amendment to this Registration Statement or in any document that is or is deemed to be incorporated by reference herein modifies or supersedes such statement.
Under no circumstances shall any information furnished prior to or subsequent to the date hereof under Item 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.
Item 4. | Description of Securities |
This item is not applicable because the class of securities of the Company to be offered under this Registration Statement (i.e., the Company’s common stock, par value $0.001 per share), is registered under Section 12 of the Securities Exchange Act of 1934, as amended.
2 |
Item 8. | Exhibits |
The following exhibits are filed with this registration statement or are incorporated by reference as a part of this Registration Statement:
3 |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Fe, State of New Mexico, on November 30, 2018.
SIGMA LABS, INC. | ||
By: | /s/ John Rice | |
John Rice | ||
President and Chief Executive Officer |
Each person whose signature appears below constitutes and appoints John Rice as his true and lawful attorney-in-fact and agent, with full power of substitution, for him in any and all capacities, to sign this registration statement on Form S-8 and any amendments hereto (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as he might do or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may do or cause to be done by virtue of this power of attorney.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated and on November 30, 2018.
Signature | Title | |
/ s/ JOHN RICE | President, Chief Executive Officer (principal executive officer) and Chairman of the Board | |
John Rice | ||
/s/ NANNETTE TOUPS | Chief Financial Officer, Treasurer and Secretary (principal financial and accounting officer) | |
Nannette Toups | ||
/s/ SALVATORE BATTINELLI | Director | |
Salvatore Battinelli | ||
/s/ DENNIS DUITCH | Director | |
Dennis Duitch | ||
/s/ FRANK J. GAROFALO | Director | |
Frank J. Garofalo | ||
/s/ KENT SUMMERS | Director | |
Kent Summers |
4 |
EXHIBIT INDEX
The following exhibits are filed with this registration statement or are incorporated by reference as a part of this Registration Statement:
5 |
1 Year Sigma Labs Chart |
1 Month Sigma Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions